Document Detail


Triglyceride response to an intensive lifestyle intervention is enhanced in carriers of the GCKR Pro446Leu polymorphism.
MedLine Citation:
PMID:  21525158     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
CONTEXT: Glucokinase regulatory protein (GCKR) regulates the trafficking and enzymatic activity of hepatic glucokinase, the rate-limiting enzyme in glycogen synthesis and glycolysis. The intronic single-nucleotide polymorphism (SNP) rs780094 (intron 16) and the missense SNP rs1260326 (P446L) in the GCKR gene are strongly associated with increased circulating triglyceride and C-reactive protein levels and, paradoxically, reductions in diabetes incidence, fasting glucose levels, and insulin resistance. OBJECTIVE, SETTING, AND PATIENTS: We sought to replicate these associations and evaluate interactions with lifestyle and metformin interventions in the multiethnic Diabetes Prevention Program (DPP).
INTERVENTIONS AND MAIN OUTCOME MEASURES: We genotyped the two GCKR SNP in 3346 DPP participants and evaluated association with progression to diabetes and both baseline levels and changes in triglycerides, homeostasis model assessment of insulin resistance (HOMA-IR), oral disposition index, and inflammatory markers along with their interactions with DPP interventions.
RESULTS: GCKR variation did not predict development of type 2 diabetes. At baseline, the 446L allele was associated with higher triglyceride and C-reactive protein levels (both P < 0.0001) and lower fasting glucose (P = 0.001) and HOMA-IR (P = 0.06). The lifestyle intervention was associated with a decrease in magnitude of the effect of the 446L allele on triglyceride levels (interaction P = 0.04). Metformin was more effective in reducing HOMA-IR in carriers of the P446 allele (interaction P = 0.05).
CONCLUSIONS: Intensive lifestyle intervention appears to partially mitigate the effect of the 446L allele on higher triglycerides, whereas the P446 allele appears to enhance responsiveness to the HOMA-IR-lowering effect of metformin.
Authors:
Toni I Pollin; Kathleen A Jablonski; Jarred B McAteer; Richa Saxena; Sekar Kathiresan; Steven E Kahn; Ronald B Goldberg; David Altshuler; Jose C Florez;
Related Documents :
2161118 - Decrease in endothelium-dependent relaxation and levels of cyclic nucleotides in aorta ...
1254108 - Department of medicina, faculdade de medicina da universidade de são paulo, brazil.
6241788 - A time-course study of submandibular kallikrein, blood glucose and insulin of alloxan-d...
720388 - Protection against alloxan-induced diabetes in mice by the hydroxyl radical scavenger d...
10490778 - Inhibitory effect of enterostatin on the beta cell response to digestive insulinotropic...
21864398 - Simultaneous utilization of glucose and xylose for lipid production by trichosporon cut...
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.     Date:  2011-04-27
Journal Detail:
Title:  The Journal of clinical endocrinology and metabolism     Volume:  96     ISSN:  1945-7197     ISO Abbreviation:  J. Clin. Endocrinol. Metab.     Publication Date:  2011 Jul 
Date Detail:
Created Date:  2011-07-07     Completed Date:  2011-09-12     Revised Date:  2012-04-16    
Medline Journal Info:
Nlm Unique ID:  0375362     Medline TA:  J Clin Endocrinol Metab     Country:  United States    
Other Details:
Languages:  eng     Pagination:  E1142-7     Citation Subset:  AIM; IM    
Affiliation:
Division of Endocrinology, Diabetes, and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland21201, USA. dppmail@bsc.gwu.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adaptor Proteins, Signal Transducing / genetics*,  metabolism
Alleles
Blood Glucose / genetics
C-Reactive Protein / metabolism
Diabetes Mellitus, Type 2 / genetics*,  metabolism,  prevention & control
Disease Progression
Female
Genetic Predisposition to Disease
Genotype
Heterozygote
Humans
Insulin Resistance / genetics
Life Style*
Male
Polymorphism, Single Nucleotide
Triglycerides / blood
Grant Support
ID/Acronym/Agency:
R01 DK072041/DK/NIDDK NIH HHS; R01 DK072041-08/DK/NIDDK NIH HHS
Chemical
Reg. No./Substance:
0/Adaptor Proteins, Signal Transducing; 0/Blood Glucose; 0/GCKR protein, human; 0/Triglycerides; 9007-41-4/C-Reactive Protein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of Risedronate and Low-Dose Transdermal Testosterone on Bone Mineral Density in Women with A...
Next Document:  Increased Risk for Non-Autoimmune Hypothyroidism in Young Patients with Congenital Heart Defects.